Alteration of thiamine pharmacokinetics by end-stage renal disease (ESRD)

International Journal of Clinical Pharmacology and Therapeutics

Volumn 37, Issue 9, 1999, Pages 449-455

  Frank, T ^a   Bitsch, R ^a   Maiwald, J ^a   Stein, G ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Benfotiamin; End stage renal disease; Pharmacokinetics; Thiamine diphosphate; Transketolase

Indexed keywords

BENFOTIAMINE; COCARBOXYLASE; NEUROTRAT S FORTE; THIAMINE DERIVATIVE; THIAMINE MONONITRATE; THIAMINE PHOSPHATE; TRANSKETOLASE; UNCLASSIFIED DRUG; VITAMIN B COMPLEX;

ADULT; AREA UNDER THE CURVE; ARTICLE; CELL LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG METABOLISM; DRUG URINE LEVEL; ENZYME ACTIVATION; ERYTHROCYTE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; KIDNEY FAILURE; MALE; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL;

EID: 0032864993     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Bailey AL, Finglas PM, Wright AJA, Southon S 1994 Thiamin intake, erythrocyte transketolase activity and total erythrocyte thiamine in adolescents. Br J Nutr 72: 111-125
2. Baker H, Frank O 1976 Absorption, utilization, and clinical effectiveness of allithiamines compared to water-soluble thiamines. J Nutr Sci Vitaminol 22 (Suppl): 63-68
3. Bitsch R, Wolf M, Möller J, Heuzeroth L, Grüneklee D 1991 Bioavailability assessment of the lipophilic benfotiamine as compared to a water-soluble thiamin derivative. Ann Nutr Metab 35: 292-296
4. Bostom AG, Shemin D, Lapone KL, Miller JW, Sutherland P, Nadeau M, Seyoum E, Hartman W, Prior R, Wilson PW 1995 Hyperhomocysteinemia and traditional cardiovascular disease risk factors in end-stage renal disease patients on dialysis: a case-control study. Atherosclerosis 114: 93-103
5. Brunnekreeft JWI, Eidhof H, Gerrits J 1989 Optimized determination of thiochrome derivatives of thiamine and thiamine phosphates in whole blood by reversed-phase liquid chromatography with precolumn derivatization. J Chromatogr 491: 88-96
6. Food and Nutrition Board 1998 Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline (Prepublication Copy). National Academy Press, Washington, DC
7. Fujiwara M 1965 Absorption, excretion and fate of thiamine and its derivatives in human body. In: Shimazono Y, Katsura N (eds): Review of Japanese Literature on Beriberi and Thiamin Research Commitee of Japan, Kyoto. Igaku Shoin Ltd, Tokyo, pp 179-213
8. Greb A, Bitsch R 1998 Comparative bioavailability of various thiamine derivatives after oral administration. Int J Clin Pharmacol Ther 36: 216-221
9. Hilbig R, Rahmann H 1998 Comparative audioradiographic investigations on the tissue distribution of benfotiamine versus thiamine in mice. Arzneimittelforschung 48: 461-168
10. Itokawa Y, Nishino K, Igarashi S 1992 Evaluation of thiamin derivatives - Human bioavailability, uptake by human blood cells and conversion to thiamin by rat liver homogenate. Vitamin (Japan) 66: 35-42
11. Kawasaki T 1992 Modern chromatographic analysis of vitamins. In: De Leenheer AP, Lambert WE, Nelis HJ (eds) Thiamin (2nd ed). Dekker, New York, pp 319-354
12. Kühler W, Andersen HJ, Heeschen W, Kohlmeier M 1992 Methodenhandbuch der Verbundstudie Ernährungserhebung und Risikofaktoren Analytik (Vol 1). Dr. Fleck, Niederkleen, pp 79-81
13. Loew D 1996 Pharmacokinetics of thiamine derivatives especially of benfotiamine. Int J Clin Pharmacol Ther 34: 47-50
14. Makoff R 1991 Water-soluble vitamin status in patients with renal disease treated with bemodialysis or peritoneal dialysis. J Ren Nutr 1: 56
15. Masson MR, Quincy C, Girard P, Later R, Bochu M, Cotte M-F 1966 Etude comparative du taux de thiaminémie pres injection de chlorhydrate de thiamine et prise per os de Benfotiamine. Lyon Med 216: 685-704
16. Pietrzak I, Baczyk K 1997 Comparison of the thiamine level in blood and erythrocyte transketolase activity in hemodialyzed and nondialyzed patients during recombinant human erythropoietin therapy. Miner Electrolyte Metab 23: 277-282
17. Pietrzik K, Remer T 1989 Zur Bioverfügbarkeitsprüfung von Mikronährstoffen. Z Ernährungswiss 28: 130-141
18. Schreeb KH, Freudenthaler S, Vormfelde SV, Gundert-Remy U, Gleiter CH 1997 Comparative bioavailability of two vitamin B1 preparations: Benfotiamine and thiamine mononitrate. Eur J Clin Pharmacol 52: 319-320
19. Stein G, Sperschneider H, Koppe S 1985 Vitamin levels in chronic renal failure and need for supplementation. Blood Purif 3: 52-62
20. Tallaksen CME, Sande A, Boehmer T, Bell H, Karlsen J 1993 Kinetics of thiamin and thiamin phosphate esters in human blood, plasma and urine after 50 mg intravenously or orally. Eur J Clin Pharmacol 44: 73-78
21. Thieler H 1993 Die Dialysebehandlung bei chronischer Niereninsuffizienz. Zbl Chir 118: 118-121
22. Thomann P 1993 Non-compartmental analysis methods manual. In: Heinzel G, Woloszczak R, Thomann P (eds) TopFit Version 2.0 - Pharmacokinetic and Pharmacodynamic Data Analysis System for the PC (1st ed). Fischer, Jena, pp II-4-II-65
23. Wada T, Takagi H, Minakami H, Hamanka W, Okamoto K, Ito A, Sahashi Y 1961 A new thiamine derivative, S-benzoylthiamine O-monophosphate. Science 134: 195-196
24. Warnock LG, Prudhomme CR, Wagner C 1978 The determination of thiamin pyrophosphate in blood and other tissues and its correlation with erythrocyte transketolase activity. J Nutr 108: 421-427
25. Wolf M 1995 Untersuchungen zur Bioverfügbarkeit von Thiaminderivaten unter besonderer Berücksichtigung von S-Benzoylthiamin-O-Monophosphat. Doctoral Thesis, Friedrich-Schiller-University, Jena
26. Ziems M 1997 Zur Biokinetik des S-Benzoylthiamin-o-monophosphats bei gesunden Männern - Analyse mit Metaboliten-Modellen. Doctoral Thesis, Dr. Fleck, Niederkleen